Editorial: The Role of Sphingolipid Metabolism in the Development of Type 2 Diabetes and Obesity
Front Endocrinol (Lausanne)
.
2022 Jan 7:12:835751.
doi: 10.3389/fendo.2021.835751.
eCollection 2021.
Authors
Agnieszka Blachnio-Zabielska
1
,
Eric Hajduch
2
,
Hervé Le Stunff
3
Affiliations
1
Epidemiology and Metabolic Disorders Department, Medical University of Bialystok, Bialystok, Poland.
2
Centre de Recherche des Cordeliers, INSERM, Sorbonne Université, Paris, France.
3
Université Paris-Saclay, CNRS UMR 9197, Institut des Neurosciences Paris-Saclay, Saclay, France.
PMID:
35069458
PMCID:
PMC8777266
DOI:
10.3389/fendo.2021.835751
No abstract available
Keywords:
ApoM; biomarkers; ceramides; lipotoxicity; sphingosine-1-phosphate; type 2 diabetes.
Publication types
Editorial
Research Support, Non-U.S. Gov't
Introductory Journal Article